FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4287559969> ?p ?o ?g. }

• W4287559969 abstract "Dear Editor, Dapsone is a dual-function drug with antimicrobial and antiprotozoal effects and anti-inflammatory features (1). In dermatology, it is a first choice for conditions such as leprosy, IgA pemphigus, dermatitis herpetiformis, and linear IgA bullous dermatosis, or an adjunctive treatment for, e.g. bullous pemphigoid (BP) and pemphigus vulgaris (1). However, dapsone is associated with some adverse effects, including methemoglobinemia (1). Methemoglobin (MetHb) concentrations of less than 15% usually cause no symptoms in patients with normal hemoglobin concentrations (2). Herein, we report the case of a patient with BP who developed dyspnea because of dapsone-induced methemoglobinemia that was as mild as 4.7%. A 93-year-old man was diagnosed with BP based on skin manifestations (Figure 1, a and b), histopathological findings (Figure 1, c and d), and anti-BP180 NC16A antibody titer determined by chemiluminescence enzyme immunoassay (279 U/mL) 3 years earlier. His comorbidities included diabetes mellitus, chronic heart failure, right pleural effusion, and brain infarction. The patient had been successfully treated with oral prednisolone, so the steroid was tapered to 4 mg/day. The blisters recurred, however, and new ones kept developing even though the prednisolone was increased to 25 mg/day. Dapsone (75 mg/day) was begun as adjunctive treatment, and new blister formation ceased. At one week from dapsone initiation, the patient developed dyspnea, and his oxygen saturation as measured by pulse oximetry decreased to 88% on room air. At presentation, his blood pressure was 118/78 mmHg, the heart rate was 95 beats/minute, and axillary temperature was 36.3 °C. Neurological examination and consciousness findings remained unchanged compared with findings before dyspnea onset. Chest examination showed normal breath and heart sounds, but lip and peripheral cyanosis was present. Blood tests revealed a white blood cell count of 12,920/μl; red blood cells, 370×104/μl; hemoglobin, 11.7 g/dl; and CMV antigenemia (or C7-HRP), negative. Chest CT and echocardiography indicated no remarkable change compared with imaging from one year earlier. Arterial blood gas analysis showed a pH of 7.454, PaO2 63.1 mmHg, PaCO2 35.4 mmHg, HCO3- 24.3 mmol/L, SaO2 92.4%, and MetHb of 4.7%. These findings indicated a saturation gap (difference between SpO2 and SaO2) induced by MetHb. Upon cessation of dapsone, MetHb levels and SpO2 returned to normal and the dyspnea resolved, implicating dapsone in the methemoglobinemia (Figure 1, e). Differential diagnoses were pulmonary disease, heart disease, neuromuscular disease, sepsis, and drug intoxication. These possibilities were ruled out by the physical examination, drug history, vital signs, blood tests, and chest CT and echocardiography. In normal individuals, MetHb levels are less than 1% (2). Healthy patients with normal hemoglobin concentrations develop cyanosis at MetHb level of 15-20%, dyspnea at 20-50%, and coma at 50-70%, and die at more than 70% (2). However, patients with hematologic disease, acidosis, or cardiopulmonary diseases, for example, present with symptoms even with MetHb levels less than 15% (2,3). We inferred that our patient presented with dyspnea even under mild methemoglobinemia because he had anemia, chronic heart failure, and right pleural effusion. The occurrence of dapsone-induced methemoglobinemia with obvious symptoms is rare (1,4). Clinicians should be aware that methemoglobinemia symptoms are influenced not only by MetHb concentrations but also by comorbidities." @default.
• W4287559969 created "2022-07-25" @default.
• W4287559969 creator A5001357732 @default.
• W4287559969 creator A5013296526 @default.
• W4287559969 creator A5016106271 @default.
• W4287559969 creator A5069434271 @default.
• W4287559969 creator A5081158534 @default.
• W4287559969 date "2020-12-01" @default.
• W4287559969 modified "2023-09-28" @default.
• W4287559969 title "A Case of Dapsone-induced Mild Methemoglobinemia with Dyspnea and Cyanosis." @default.
• W4287559969 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33835002" @default.
• W4287559969 hasPublicationYear "2020" @default.
• W4287559969 type Work @default.
• W4287559969 citedByCount "0" @default.
• W4287559969 crossrefType "journal-article" @default.
• W4287559969 hasAuthorship W4287559969A5001357732 @default.
• W4287559969 hasAuthorship W4287559969A5013296526 @default.
• W4287559969 hasAuthorship W4287559969A5016106271 @default.
• W4287559969 hasAuthorship W4287559969A5069434271 @default.
• W4287559969 hasAuthorship W4287559969A5081158534 @default.
• W4287559969 hasConcept C126322002 @default.
• W4287559969 hasConcept C159654299 @default.
• W4287559969 hasConcept C16005928 @default.
• W4287559969 hasConcept C203014093 @default.
• W4287559969 hasConcept C26865036 @default.
• W4287559969 hasConcept C2776715498 @default.
• W4287559969 hasConcept C2777640609 @default.
• W4287559969 hasConcept C2777737778 @default.
• W4287559969 hasConcept C2778728583 @default.
• W4287559969 hasConcept C2778917026 @default.
• W4287559969 hasConcept C2779134260 @default.
• W4287559969 hasConcept C2779252107 @default.
• W4287559969 hasConcept C42219234 @default.
• W4287559969 hasConcept C71924100 @default.
• W4287559969 hasConcept C90924648 @default.
• W4287559969 hasConceptScore W4287559969C126322002 @default.
• W4287559969 hasConceptScore W4287559969C159654299 @default.
• W4287559969 hasConceptScore W4287559969C16005928 @default.
• W4287559969 hasConceptScore W4287559969C203014093 @default.
• W4287559969 hasConceptScore W4287559969C26865036 @default.
• W4287559969 hasConceptScore W4287559969C2776715498 @default.
• W4287559969 hasConceptScore W4287559969C2777640609 @default.
• W4287559969 hasConceptScore W4287559969C2777737778 @default.
• W4287559969 hasConceptScore W4287559969C2778728583 @default.
• W4287559969 hasConceptScore W4287559969C2778917026 @default.
• W4287559969 hasConceptScore W4287559969C2779134260 @default.
• W4287559969 hasConceptScore W4287559969C2779252107 @default.
• W4287559969 hasConceptScore W4287559969C42219234 @default.
• W4287559969 hasConceptScore W4287559969C71924100 @default.
• W4287559969 hasConceptScore W4287559969C90924648 @default.
• W4287559969 hasLocation W42875599691 @default.
• W4287559969 hasOpenAccess W4287559969 @default.
• W4287559969 hasPrimaryLocation W42875599691 @default.
• W4287559969 hasRelatedWork W13070444 @default.
• W4287559969 hasRelatedWork W13436658 @default.
• W4287559969 hasRelatedWork W1819807 @default.
• W4287559969 hasRelatedWork W18334653 @default.
• W4287559969 hasRelatedWork W4109903 @default.
• W4287559969 hasRelatedWork W4526179 @default.
• W4287559969 hasRelatedWork W4741972 @default.
• W4287559969 hasRelatedWork W7826148 @default.
• W4287559969 hasRelatedWork W8139740 @default.
• W4287559969 hasRelatedWork W1876088 @default.
• W4287559969 isParatext "false" @default.
• W4287559969 isRetracted "false" @default.
• W4287559969 workType "article" @default.